News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roxane Laboratories, Inc. Announces the Launch of Risperidone Oral Solution 1mg/mL


7/30/2009 9:50:03 AM

COLUMBUS, Ohio, July 29 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Risperidone Oral Solution, 1mg/mL by the U.S. Food and Drug Administration. The product is available in 30mL bottles for immediate shipment to wholesalers and pharmacies nationwide.

Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES